Recent News

• 05.29.2026 - Arvinas to Present at Jefferies Global Healthcare Conference
• 05.12.2026 - Arvinas Reports First Quarter 2026 Financial Results and Provides Corporate Update
• 05.01.2026 - Arvinas Announces FDA Approval of VEPPANU (vepdegestrant) for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer

Recent Filings

• 05.22.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.20.2026 - 144 Report of proposed sale of securities
• 05.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.13.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.12.2026 - 8-K Current report
• 05.12.2026 - EX-99.1 EX-99.1
• 05.12.2026 - 8-K Current report